Skip to main content

letter

. 1995 Sep 23;311(7008):807. doi: 10.1136/bmj.311.7008.807a

Serum cholesterol concentrations in parasuicide. Depression may cause low cholesterol.

M R Law, N J Wald

PMCID: PMC2550797 PMID: 7580451

807

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Gallerani M., Manfredini R., Caracciolo S., Scapoli C., Molinari S., Fersini C. Serum cholesterol concentrations in parasuicide. BMJ. 1995 Jun 24;310(6995):1632–1636. doi: 10.1136/bmj.310.6995.1632. [DOI] [PMC free article] [PubMed] [Google Scholar]
Keech A., Collins R., MacMahon S., Armitage J., Lawson A., Wallendszus K., Fatemian M., Kearney E., Lyon V., Mindell J. Three-year follow-up of the Oxford Cholesterol Study: assessment of the efficacy and safety of simvastatin in preparation for a large mortality study. Eur Heart J. 1994 Feb;15(2):255–269. doi: 10.1093/oxfordjournals.eurheartj.a060485. [DOI] [PubMed] [Google Scholar]
Law M. R., Thompson S. G., Wald N. J. Assessing possible hazards of reducing serum cholesterol. BMJ. 1994 Feb 5;308(6925):373–379. doi: 10.1136/bmj.308.6925.373. [DOI] [PMC free article] [PubMed] [Google Scholar]
Magni G., Garreau M., Orofiamma B., Palminteri R. Fengabine, a new GABAmimetic agent in the treatment of depressive disorders: an overview of six double-blind studies versus tricyclics. Neuropsychobiology. 1989;20(3):126–131. doi: 10.1159/000118485. [DOI] [PubMed] [Google Scholar]
Wysowski D. K., Gross T. P. Deaths due to accidents and violence in two recent trials of cholesterol-lowering drugs. Arch Intern Med. 1990 Oct;150(10):2169–2172. [PubMed] [Google Scholar]

ACTIONS

RESOURCES